Chappell PB - Search Results

1

Neuroendocrine and behavioral effects of the selective kappa agonist spiradoline in Tourette's syndrome: a pilot study.

Chappell PB, Leckman JF, Scahill LD, Hardin MT, Anderson G, Cohen DJ. Chappell PB, et al. Psychiatry Res. 1993 Jun;47(3):267-80. doi: 10.1016/0165-1781(93)90084-t. Psychiatry Res. 1993. PMID: 8396784 Clinical Trial.

2

Elevated CSF dynorphin A [1-8] in Tourette's syndrome.

Leckman JF, Riddle MA, Berrettini WH, Anderson GM, Hardin M, Chappell P, Bissette G, Nemeroff CB, Goodman WK, Cohen DJ. Leckman JF, et al. Life Sci. 1988;43(24):2015-23. doi: 10.1016/0024-3205(88)90575-9. Life Sci. 1988. PMID: 2463450 Free article.

3

Enhanced stress responsivity of Tourette syndrome patients undergoing lumbar puncture.

Chappell P, Riddle M, Anderson G, Scahill L, Hardin M, Walker D, Cohen D, Leckman J. Chappell P, et al. Biol Psychiatry. 1994 Jul 1;36(1):35-43. doi: 10.1016/0006-3223(94)90060-4. Biol Psychiatry. 1994. PMID: 8080901

4

Elevated cerebrospinal fluid corticotropin-releasing factor in Tourette's syndrome: comparison to obsessive compulsive disorder and normal controls.

Chappell P, Leckman J, Goodman W, Bissette G, Pauls D, Anderson G, Riddle M, Scahill L, McDougle C, Cohen D. Chappell P, et al. Biol Psychiatry. 1996 May 1;39(9):776-83. doi: 10.1016/0006-3223(95)00221-9. Biol Psychiatry. 1996. PMID: 8731518 Free article.

5

Neuroendocrine and behavioral effects of naloxone in Tourette syndrome.

Chappell PB, Leckman JF, Riddle MA, Anderson GM, Listwack SJ, Ort SI, Hardin MT, Scahill LD, Cohen DJ. Chappell PB, et al. Adv Neurol. 1992;58:253-62. Adv Neurol. 1992. PMID: 1414631 Review. No abstract available.

6

Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette's syndrome and healthy controls.

Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, Anderson GM, Riddle MA, McSwiggan-Hardin M, McDougle CJ, et al. Leckman JF, et al. Among authors: chappell pb. Arch Gen Psychiatry. 1994 Oct;51(10):782-92. doi: 10.1001/archpsyc.1994.03950100030003. Arch Gen Psychiatry. 1994. PMID: 7524462

7

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.

Chappell PB, Riddle MA, Scahill L, Lynch KA, Schultz R, Arnsten A, Leckman JF, Cohen DJ. Chappell PB, et al. J Am Acad Child Adolesc Psychiatry. 1995 Sep;34(9):1140-6. doi: 10.1097/00004583-199509000-00010. J Am Acad Child Adolesc Psychiatry. 1995. PMID: 7559307

8

Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report.

Lombroso PJ, Scahill L, King RA, Lynch KA, Chappell PB, Peterson BS, McDougle CJ, Leckman JF. Lombroso PJ, et al. Among authors: chappell pb. J Am Acad Child Adolesc Psychiatry. 1995 Sep;34(9):1147-52. doi: 10.1097/00004583-199509000-00011. J Am Acad Child Adolesc Psychiatry. 1995. PMID: 7559308 Free article.

9

Videotape tic counts in the assessment of Tourette's syndrome: stability, reliability, and validity.

Chappell PB, McSwiggan-Hardin MT, Scahill L, Rubenstein M, Walker DE, Cohen DJ, Leckman JF. Chappell PB, et al. J Am Acad Child Adolesc Psychiatry. 1994 Mar-Apr;33(3):386-93. doi: 10.1097/00004583-199403000-00013. J Am Acad Child Adolesc Psychiatry. 1994. PMID: 8169184 Free article.

10

Patterns of response to acute naloxone infusion in Tourette's syndrome.

van Wattum PJ, Chappell PB, Zelterman D, Scahill LD, Leckman JF. van Wattum PJ, et al. Among authors: chappell pb. Mov Disord. 2000 Nov;15(6):1252-4. doi: 10.1002/1531-8257(200011)15:6<1252::aid-mds1030>3.0.co;2-i. Mov Disord. 2000. PMID: 11104215 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters